Everything published about Eloralintide: mechanism, research areas, results, regimens, risks, comparisons — plus the dated Vietnam price and ordering rules.
| Format | Price (index Nov 2, 2026) | Delivery |
|---|---|---|
| 10 mg | from 2 400 000 ₫ | Da Nang ~30 min · Vietnam 1–2 days |
Eloralintide is a synthetic peptide studied for appetite control and weight reduction. It acts through the amylin system, which helps signal fullness and regulate eating behaviour.
An investigational, selective amylin receptor agonist. Its development explores a weight-management approach distinct from GLP-1 receptor activation.
A selective amylin peptide at the forefront of appetite-control research, with substantial phase 2 results and a mechanism distinct from GLP-1.
The 9 mg group had approximately 20% average weight reduction at 48 weeks, versus 0.4% with placebo, using the trial's efficacy analysis. The amount of weight change varied across dose groups.
Phase 2 research schedule: Subcutaneous administration once weekly for 48 weeks. Fixed-dose groups: 1 mg, 3 mg, 6 mg or 9 mg weekly. Separate escalation groups increased from 6 to 9 mg or from 3 to 6 to 9 mg. These are distinct trial arms.
The main reported effects were nausea and other gastrointestinal symptoms. Lower-dose groups generally had better tolerability; longer-term follow-up continues.
Both investigate amylin-related appetite control. Eloralintide was developed with greater amylin-receptor selectivity. Different trials, populations and regimens prevent a simple claim that one is universally better.
from 2 400 000 ₫ for 10 mg (index Nov 2, 2026); final total confirmed in writing before payment.
No: research material, not a prescription drug; no medical claims.